EUVIMEDEUVIMED entdecken
Kohortenstudie

Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node‐Negative Early‐Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study

Zhuqin Xiang, Bokai Yun, Wenjin Wang, Gan Xiong, Chen Yi, Jinqi Zhang, Yaqi Huang, Linlin Ren, Nan Xie, Zehang Zhuang, Jinsong Hou, Cheng Wang

Oral Diseases · 11.06.2026

DOI: 10.1111/odi.70387 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Oral Diseases, online erschienen am 11.06.2026. Verfasst von Zhuqin Xiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Neck Dissection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The optimal management of early‐stage oral squamous cell carcinoma (OSCC) with clinically node‐negative neck remains controversial. A reliable biomarker to stratify occult metastasis risk for elective neck dissection (END) is lacking.

Methods

This retrospective cohort included 231 early‐stage cN0 OSCC patients. Tumor budding (TB) was graded by ITBCC criteria. Survival was analyzed using Kaplan–Meier and Cox regression; subgroup and additive interaction were tested.

Results

High‐grade TB was found in 55.4% (128/231) and associated with poorer 5‐year OS (80.4% vs. 93.0%, p = 0.0059) and DFS (66.2% vs. 80.6%, p = 0.019). END (67.5%, 156/231) independently improved OS (HR = 0.28, p < 0.001) and DFS (HR = 0.35, p = 0.003). In high‐grade TB patients, END markedly raised 5‐year OS (88.1% vs. 60.0%, p < 0.001) and DFS (76.2% vs. 39.8%, p < 0.001), with significant additive interaction (RERI = 7.12). No OS benefit was seen in low‐TB patients.

Conclusion

TB effectively stratifies END benefit. END is recommended for high‐grade TB early stage cN 0 OSCC, while watch‐and‐wait is suitable for low‐grade TB patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCarcinoma, Squamous CellNeck DissectionHumansRetrospective StudiesNeoplasm StagingFemaleMaleMiddle AgedAgedElective Surgical ProceduresLymphatic Metastasis

Stichwörter der Autor:innen

elective neck dissectionoral and maxillofacial surgeryoral squamous cell carcinomaretrospective cohort studytumor budding

Autor:innen und Institutionen

  • Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China.
  • Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiang, Z., Yun, B., Wang, W., Xiong, G., Yi, C., Zhang, J., Huang, Y., Ren, L., Xie, N., Zhuang, Z., Hou, J., & Wang, C. (2026). Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node‐Negative Early‐Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study. Oral Diseases. https://doi.org/10.1111/odi.70387

Vancouver

Xiang Z, Yun B, Wang W, Xiong G, Yi C, Zhang J, et al. Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node‐Negative Early‐Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study. Oral Diseases. 2026. doi:10.1111/odi.70387

BibTeX
@article{Xiang2026,
  author = {Xiang, Zhuqin and Yun, Bokai and Wang, Wenjin and Xiong, Gan and Yi, Chen and Zhang, Jinqi and Huang, Yaqi and Ren, Linlin and Xie, Nan and Zhuang, Zehang and Hou, Jinsong and Wang, Cheng},
  title = {Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node‐Negative Early‐Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study},
  journal = {Oral Diseases},
  year = {2026},
  doi = {10.1111/odi.70387}
}
Kostenlos starten →